THE GLOBAL PHARMACEUTICAL INDUSTRY

1. EXECUTIVE SUMMARY

SUMMARY AND KEY PAGES OF THE REPORT

The summary provides all the elements needed to understand the major trends in the sector and foreseeable developments, drawing on analyses of the market outlook and the strategies of the companies.

2. SUMMARY

Summary

Key slides

3. SECTOR FUNDAMENTALS

SCOPE OF THE REPORT

OVERVIEW

BUSINESS FUNDAMENTALS

4. THE MARKET AND LEADERS' ACTIVITY

THE SECTOR ENVIRONMENT

• Overview

• Economic factors

• The role of public authorities

• Socio-demographic factors

• Technological factors

• Environmental factors

THE GLOBAL PHARMACEUTICAL MARKET

• Global sales of medicines

• Breakdown of global drug sales by brand

• Global sales of speciality drugs

• Focus on biotech

• Focus on oncology

• Focus on immunology

• Geographical breakdown of the global pharmaceuticals market

• Outlook for the global pharmaceutical market

• Outlook for worldwide sales of medicines by therapeutic area

• Outlook for global drug sales by geographic region

• R&D expenditure

• Geographical breakdown of R&D expenditure

• Geographical distribution of new drug launches

• Global drug consumption

• Global drug consumption by region

• Geographical breakdown of global drug consumption

• Global drug consumption by therapeutic area

• Global exports of pharmaceutical products

• Pharmaceutical exporting countries

• Pharmaceutical product importing countries

• United States

• Europe

• China

• Japan

• Emerging countries

ACTIVITY AND LEADERS' PERFORMANCES

• Leaders' cumulative revenue

• Ranking by revenue

• Market share of market leaders

• Ranking by revenue growth rate

• Aggregate operating income of the leaders

• Leaders by EBIT margin

• Geographical breakdown of sales

• Key performance indicators

5. COMPETITION AND LEADERS' STRATEGIES

COMPETITIVE ENVIRONMENT

• Porter's 5 forces (Overview)

• Competitive intensity

• Threat of new entrants

• Government's influence

• Threat of substitutes

• Bargaining power of suppliers

LEADERS' STRATEGIES

• Overview

• Rationalisation of drug portfolios

• Redeployment of activities to specialty medicine

• Increasing R&D efforts

• Expanding and modernising production and innovation capacity

• Improving the environmental balance

• The digital transformation of businesses

• Pursuing the strategy of external growth and partnership

6. FORCES AT WORK

• Rankings of the 10 world leaders in the global pharmaceutical industry

• Key performance indicators of the 10 leaders (revenue growth and EBIT rate)

• SWOT analysis of the 10 leaders

7. LEADERS' PROFILES

• AbbVie

• AstraZeneca

• Bristol-Myers Squibb

• GSK

• Johnson & Jonhnson

• Merck & co

• Novartis

• Pfizer

• Roche

• Sanofi